|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61P 37/02 | (2006.01) |
| (11) | Number of the document | 3004166 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14733922.0 |
| Date of filing the European patent application | 2014-06-03 | |
| (97) | Date of publication of the European application | 2016-04-13 |
| (45) | Date of publication and mention of the grant of the patent | 2019-11-20 |
| (46) | Date of publication of the claims translation | 2019-12-27 |
| (86) | Number | PCT/US2014/040695 |
| Date | 2014-06-03 |
| (87) | Number | WO 2014/197470 |
| Date | 2014-12-11 |
| (30) | Number | Date | Country code |
| 201361830919 P | 2013-06-04 | US |
| (72) |
STAHL, Neil, US
ORENGO, Jamie, M., US
MURPHY, Andrew, J., US
GANDHI, Namita, US
GRAHAM, Neil, US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Alergeno atžvilgiu specifinės imunoterapijos sustiprinimo būdai, įvedant IL-4R inhibitorių |
| METHODS FOR ENHANCING ALLERGEN-SPECIFIC IMMUNOTHERAPY BY ADMINISTERING AN IL-4R INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 12 | 289.00 EUR |
| 2026-06-03 |